シミュレイション内科　心筋梗塞・狭心症を探る

出版社： 永井書店
著者：
発行日： 2006-05-25
分野： 臨床医学：内科  >  心臓
ISBN： 4815917442
電子書籍版： 2006-05-25 （初版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

9,350 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

4,675 円(税込)

購入する

商品紹介

本書は、まず総説において虚血性心疾患の病態としての動脈硬化の成因や心筋虚血、壊死の病態生理、そして最新の画像診断法と薬物および非薬物療法について解説し、さらに心筋梗塞と狭心症の各々について病態と治療を詳述した。

目次

  • シミュレイション内科　心筋梗塞・狭心症を探る

    ―目次―

    総論
    1．虚血性心疾患の分類と疫学
    2．冠動脈硬化の血管生物学
    3．冠動脈硬化の危険因子
    4．冠循環と心筋虚血・心筋壊死
    5．冠動脈造影法
    6．虚血性心疾患の画像診断
    7．虚血性心疾患の薬物療法
    8．冠動脈インターベンション
    9．虚血性心疾患の外科療法
    10．急性心筋梗塞の症候と診断
    11．急性心筋梗塞の治療と急性期合併症
    12．心筋梗塞慢性期の治療と生命予後
    13．狭心症の分類、症候、診断
    14．狭心症の治療と生命予後

    疾患編
    1．冷汗を伴う胸痛が持続
    2．心窩部痛が続き、嘔気を認める
    3．持続性胸痛からAMIが疑われるが心電図に異常を認めない
    4．持続性胸痛からAMIが疑われるが心筋マーカーに異常を認めない
    5．心エコー検査はAMI診断だけでなく合併症の診断にも必須
    ほか

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

総論

P.7 掲載の参考文献
1) Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 59:607-609, 1979
PubMed
2) Fuster V, et al:The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242-250, 1992
PubMed
3) Braunwald E:Unstable angina. A classification. Circulation 80:410-414, 1989
PubMed
4) Campeau L:Grading of angina pectoris. Circulation 54:522-523, 1976
PubMed
5) Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association:A reporting system on patients evaluated for coronary artery disease. Circulation 51:5-40, 1975
 
6) Hamm CW, et al:A classification of unstable angina revisited, Circulation 102:118-122, 2000.
PubMed
7) The TIMI IIIB investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction; results of the TIMI IIIB trial. Circulation 89:1545-1556, 1994.
 
P.12 掲載の参考文献
1) DS Baim, W Grossman:in Grossman's Cardiac Catheterization, Angiography, and Intervention, 6th ed (DS Baim, W Grossman, eds). Baltimore, Lippincott Williams & Wlikins, 2000
 
2) 杉本恒明, ほか:内科学. 第八版第1冊. 朝倉書店.
 
3) Ross R:The pathogenesis of atherosclerosis:a perspective for the 1990s. Nature 362 (6423):801-809, 1993
PubMed
4) Libby P:Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (3):365-372, 2001
PubMed
5) Steinberg D, Parthasarathy S, Carew TE, et al:Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (14):915-924, 1989
PubMed
6) Folkman J:Tumor angiogenesis:therapeutic implications. N Engl J Med 285 (21):1182-1186, 1971
PubMed
7) Asahara T, Murohara T, Sullivan A, et al:Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (a5302):964-967, 1997
 
P.17 掲載の参考文献
1) The pooling Project Research Group:Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of malor coronary events:Final report of the Pooling Prolect. J Choron Dis 31:201-306, 1978
 
2) Kannel WB:Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 18:181-196, 1995
PubMed
3) Stokes J 3rd, Kannel WB, Wolf PA, et al:The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old:30 years of follow-up in the Framingham Study. Circulation 175:V6573, 1987
 
4) Iso H, Naito Y, Sato S, et al:Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 153:490-499, 2001
PubMed
5) Gordon DJ, Probstfield JL, Garrison RJ, et al:High-density lipoprotein cholesterol and cardiovascular disease. Four prospective Arnerican studies. Circulation 79:915, 1989
 
6) Zhou X, Paulsson G, Stemme S, et al:Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 101:1717-1725, 1998
 
7) Caligiuri G, Rudling M, Ollivier V. et al:Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 9:10-17, 2003
PubMed
8) Pinderski LJ, Fischbein MP, Subbanagounder G, et al:Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 90:1064-1071, 2002
PubMed
9) King VL, Szilvassy SJ, Daugherty A:Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/-mice. Arterioscler Thromb Vasc Biol 22:456461, 2002
 
10) Schonbeck U, Mach F, Sukhova GK, et al:Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes:a role for CD 40 signaling in plaque rupture? Circ Res 81:448-454, 1997
 
11) Libby P:Inflammation in atherosclerosis. Nature 420:868-874, 2002
PubMed
12) Soejima H, et al:Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 99:2908-2913, 1999
PubMed
13) Wilcox JN, et al:Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 86:2839-2843, 1989
 
14) Kaikita K, et al:Tissue factor expression on macrophages in coronary plaque in patients with unstable angina. Arterioscler Thromb Vasc Biol 17:2232-2237, 1997
PubMed
15) Suefuji H, et al:Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 34:253-259, 1997
 
16) Loskutoff DJ, et al:Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 9:87-115, 1989
PubMed
17) Hamsten A, et al:Plasminogen activator inhibitor in plasma:risk factor for recurrent myocardial infarction. Lancet 2:3-9, 1987
PubMed
18) Sakamoto T, et al:Association of Patency of the Infarct-related Coronary Artery With Plasma Levels of Plasminogen Activator Inhibitor Activity in Acute Myocardial Infarction. Am J Cardiol 70:271-276, 1992
PubMed
19) Masuda T, et al:Plasma Plasminogen Activator Inhibitor Activity and Tissue Plasminogen Activator Levels in Patients With Unstable Angina and Those With Coronary Spastic Angina. Am Heart J 124:314-319, 1992
PubMed
20) Takazoe K, et al:Increased plasminogen activator inhibitor activity and diabetes predict subsequent coronary events in patients with angina pectoris. Ann Med 33:206-212, 2001
PubMed
21) Reaven GM:Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
PubMed
22) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
 
23) World Health Organization:Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1:Diagnosis and Classification of Diabetes Mellitus. Genova, World Health Organization, 1999
 
P.22 掲載の参考文献
1) Boatwright RB, Downey HF, et al:Transmural variation in autoregulation of coronary blood flow in hyperperfused canine myocardium. Circ Res 47:599-609, 1980
PubMed
2) Provenza DV, Scherlis S:Coronary circulation dog's heart; demonstration of muscle sphincters in capillaries. Circ Res 7:318-324, 1959
PubMed
3) Zuberbuhler RC, Bohr DF:Responses of coronary smooth muscle to catecholamines. Circ Res 16:431-440, 1965
PubMed
4) Kelley KO, Feigl EO:Segmental alpha-receptor-mediated vasoconstriction in the canine coronary circulation. Circ Res 43:908-917, 1978
PubMed
5) Blumenthal MR, Wang HH, et al:Effects of acetylcholine on the heart. Am J Physiol 214:1280-1287,1968
PubMed
6) Hori M, Kitakaze M:Adenosine, the heart, and coronary circulation. Hypertension 18:565-574, 1991 Review
PubMed
7) Daut J, Maier-Rudolph W, et al:Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247:1341-1344, 1990
PubMed
8) Kuo L, Chancellor JD:Adenosine potentiates flow-induced dilation of coronary arterioles by activating KATP channels inendothelium. Am J Physiol 269:H541-H549,1995
PubMed
9) Wyman RM, Farhi ER, et al:Comparative effects of hypoxia and ischemia in the isolated, blood-perfused dog heart:evaluation of left ventricular diastolic chamber distensibility and wall thickness. Circ Res 64:121-128, 1989
PubMed
10) Reimer KA, et al:The wavefront phenomenon of ischemic cell death. I:Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56:786-794, 1977
PubMed
11) Reimer KA, et al:The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633-744, 1979
PubMed
12) Murry CE, Jennings RB, et al:Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986
PubMed
13) Kitakaze M. Hori M, et al:Ischemic preconditioning increases adenosine release and 5-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation 87:208-215, 1993
PubMed
14) Kitakaze M, Hori M, et al:Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5-nucleotidase activity and attenuation of adenosine release. Circulation 89:1237-1246, 1994
PubMed
15) Gross GJ, Farber NE, et al:Beneficial actions of superoxide disrnutase and catalase in stunned myocardium of dogs. Am J Physiol 250:H372-377, 1986
PubMed
16) Bolli R, Jeroudi MO, et al:Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardia "stunning" is a manifestation of reperfusion injury. Circ Res 65:607-622, 1989.
 
17) Sato H, Kitakaze M, et al:Reperfusion after brief ischemia disrupts the microtubule network in canine hearts. Circ Res 72:361-375, 1993
PubMed
18) Kusuoka H, et al:Pathophysiology and pathogenesis of stunned myocardium. Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79:950-961, 1987
PubMed
19) Hori M, et al:Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion. Circulation 84:2135-2145, 1991
PubMed
20) Kitakaze M, et al:Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest 82:920-927, 1988
PubMed
21) Kitakaze M, et al:Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation 77:685-695, 1988
PubMed
22) Murphy AM, Kogler H, Georgakopoulos D, et al:Transgenic mouse model of stunned myocardium. Science 287:488-491, 2000
PubMed
23) Cabin HS, Clubb KS, et al:Regional dysfunction by equilibrium radionuclide angiocardiography:a clinicopathologic study evaluating the relation of degree of dysfuction to the presence and extent of myocardial infarction. J Am Coll Cardiol 10:743-747, 1987
 
24) Fedele FA, Gewirtz H, et al:Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 78:729-735. 1988
PubMed
25) Kitakaze M, Marban E:Cellular mechanism of the modulation of contractile function by coronary perfusion pressure in ferret hearts. J Physiol 414:455-472, 1989
PubMed
26) Bonow RO, Dilsizian V, et al:Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 83:26-37, 1991
PubMed
27) Rahimtoola SH:The hibernating myocardium. Am Heart J 117:211-221, 1989
PubMed
28) Gaudron P, Eilles C, et al:Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87:755-763, 1993
PubMed
29) Warren SE, Royal HD, et al:Time course of left ventricular dilation after myocardial infarction:infiuence of infarct-related artery and success of coronary thrombolysis. J Am Coll Cardiol 11:12-19, 1988
 
30) Jeremy RW, Hackworthy RA, et al:Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 9:989-995, 1987
PubMed
31) Pfeffer MA, Pfeffer JM, et al:Survival after an experimental myocardial infarction:beneficial effects of long-term therapy with captopril. Circulation 72:406412, 1985
 
32) Pfeffer MA, Braunwald E, et al:Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669-677, 1992
 
33) Kober L, Torp-Pedersen C, et al:A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333:1670-1676, 1995
 
P.33 掲載の参考文献
1) AHA committee report:A reporting system on patients evaluated for coronary artery disease. Circulation 51:30-34, 1975
 
2) Chesebro JH, Knatterud G, Roberts R, et al:Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I. A comparison between intravenous plasminogen activator and intravenous streptokinase. Circulatiion 76:142-154, 1987
 
3) Scoblionko DP, Broun BG, Mitten S, et al:A new digital electoronic caliper for measurement of coronary arterial stenosis:Comparison with visual estimates and computer-assisted measurements. Am J Cardiol 53:689-693, 1984
 
4) Ambrose JA, Winters SL, Stern A, et al:Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 5:609-616, 1985
PubMed
5) Ambrose JA, Israel DH:Angiography in unstable angina. Am J Cardiol 68:78B-84B, 1991
PubMed
6) Gibbons RJ, Chatterjee K, Daley J, et al:ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina:Areport of the Amerlcan College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 33:2092-2197, 1999
 
7) Gordon PR, Abrams C, Gash AK, et al:Pericatheterization risk factors in left main coronary artery stenosis. Am J Cardiol 59:1080-1083, 1987
PubMed
8) Levin DC:Pathways and functional significance of the coronary collateral circulation. Circulation 50:831-837, 1974
PubMed
9) Rentrop KP, Cohen M, Blanke H, et al:Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5:587-592, 1985
PubMed
10) Okumura K, Yasue H, Matsuyama K, et al:Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 12:883-888, 1988
PubMed
11) 石瀬昌三, 文字直, 高桑健, ほか:選択的冠動脈内エルゴノビン投与による冠スパズムの検討. 呼吸と循環 35:191-195, 1987
 
P.41 掲載の参考文献
1) Gibbons RJ, et al:ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 41:159-168, 2003
 
2) Gottlieb SS, et al:Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339:489-497, 1998
PubMed
3) Australia-New Zealand Heart Failure Research Collaborative Group:Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 92:212-218, 1995
 
4) Alderman MH, et al:Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 349:594-598, 1997
PubMed
5) Pfeffer MA, et al:Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction:Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669-677, 1992
 
6) Lonn EM, et al:Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 90:2056-2069, 1994
PubMed
7) 日本動脈硬化学会動脈硬化性疾患診療ガイドライン2002年版.
 
8) Shub C, et al:Selection of optimal drug therapy for the patient with angina pectoris. Mayo Clin Proc 60:539, 1985
PubMed
P.47 掲載の参考文献
1) Nobuyoshi M, Kimura T, Nosaka H, et al:J Am Coll Cardiol 12:616-623, 1988
PubMed
2) Moses JW, Leon MB, Popma JJ, et al:SIRIUS Investigators. N Engl J Med 349:1315-1323, 2003
 
3) Morice MC, Serruys PW, Sousa JE, et al:RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. N Engl J Med 346:1773-1780, 2002
 
4) Serruys PW, Arterial Revascularization Therapies Study Group:Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (15):1117-24, 2001
 
P.52 掲載の参考文献
1) Hannan El, Racz MJ, MaCallister BD, et al:A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am coll Cadiol 33:63-72, 1999
 
2) Eagle KA, Guyton RA, Davidoff R, et al:ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. Circulation 110:e340-437, 2004
PubMed
3) The BARI investigators:Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status, J Am Coll Cardiol 35:1122-1129, 2000
PubMed
4) King SB IIIrd, Kosinski AS, Guyton RA, et al:Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 35:1116-1121, 2000
 
5) Dor V, DiDonato M, Sabatier M, et al:Left ventricular reconstruction by endoventricular circular patch plasty repair. A 17-year experience. Semin Thorac Cardiovasc Surg 13:435-447, 2001
 
6) Boudoulas H, Snyder GL, Lewis PR, et al:Safety and rationale for continuation of proranolol therapy during coronary bypass operation. Ann Thorac Surg 26:222, 1978
 
7) Loop FD, Lytle BW, Cosgrove DM, et al:Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 314:1-6, 1986
PubMed
8) ACC/AHA guidelines and indications for coronary artery bypass graft surgery:A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). Circulation 83:1125-1173, 1991
 
P.57 掲載の参考文献
1) Antman EM, Braunwald E:ST-elevation myocardial infarction:Pathology, pathophysiology, and clinical features. Heart disease:1141-1163
 
2) Luca GD, et al:Impaired Myocardial Perfusion Is a Major Explanation of the Poor Outcome Observed in Patients Undergoing Primary Angioplasty for ST-SegmentミElevation Myocardial Infarction and Signs of Heart Failure. Circulation 109:958-961, 2004
 
P.61 掲載の参考文献
1) Hasdai D, Califf RM, Thompson TD, et al:Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 35 (1):136-143, 2000
PubMed
2) Fibrinolytic Therapy Trialists' (FTT) Collaborative Group:Indications for fibrinolytic therapy in suspected acute myocardial infarction:collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343:311-322, 1994
 
3) Morrison LJ, Verbeek PR, McDonald AC, et al:Mortality and prehospital thrombolysis for acute myocardial infarction:A meta-analysis. JAMA 283:2686-2692, 2000
PubMed
4) Morrow DA, Antman EM, Sayah A, et al:Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction:results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. J Am Coll Cardiol 40:71-77, 2002
 
5) The GUSTO Invastigators:An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673-682, 1993
PubMed
6) Ellen CK, Judith AB, Cindy LG:Primary angioplasty versus intravenous thrombolytic for acute myocardial infarction:a quantitative revew of 23 randomised trial. Lancet 361:13-20, 2003
 
7) USIC2000 Investigators:Impact of prehospital thrombolysis for acute myocardial infarction in 1-year outcome. Results from the French Nationwide USIC 200 Registry. Circulation 110:1909-1915, 2004
 
P.71 掲載の参考文献
1) Antman EM, et al:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for Management of Patients With Acute Myocardial Infarction). pp e82-e292, 2004. www. acc. org/clinical /guidelines/stemi/index.pdf
 
2) 循環器病の診断と治療に関するガイドライン (1998-1999年度合同研究班報告). 心筋梗塞二次予防に関するガイドライン. Jpn Circ J 64 (Suppl IV):1081-1127, 2000
 
3) 日本動脈硬化学会高脂血症診療ガイドライン検討委員会. 高脂血症診療ガイドライン. 動脈硬化 25:1-34, 1997
 
4) Graham DJ, et al:Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowerng drugs. JAMA 292:2585-2590, 2004
 
5) Ishikawa K, et al:Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn Circ J 60:779-788, 1996
PubMed
6) The Japanese β-blockers and Calcium antagonists Myocardial Infarction (JBCMI) investigators:Comparison of the effects of beta-blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 93:969-973, 2004
 
7) Smith SC Jr, et al:ACC/AHA guidelines for percutaneous coronary interventions:areport of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 37:2239i-lxvi, 2001
 
8) Kim CB, et al:Potencial benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 88:242-2436, 1993
 
9) Hohnloser SH, et al:Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351:2481-2488, 2004
PubMed
10) Bahit MC, et al:Direct comparison of characteristics, treatment and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI g Trial and TIMI g Registry. Am Heart J 145:109-117, 2003
PubMed
11) Saito M, et al:Long-term prognosis of patients with acute myocardial infarction:is mortality and morbidity as low as the incidence of ischemic heart disease in Japan?Am Heart J 113:891-897, 1987
 
12) Hosoda S, et al:Follow-up of 2733 Japanese patients With myocardial infarction. Jpn Circ J 59:121-129, 1995
 
13) Sumiyoshi T, et al:Effects of interventional therapy on the outcome of acute myocardial infarction in the elderly:amulticenter collaborative study in Japan, In "Cardiovascular Disease in the Elderly". pp33-46, Tokyo, Churchill Livingstone, 1996
 
14) Kobayashi Y, et al:Effect on survival of previous angina pectoris after acute myocardial infarction. Am J Cardiol 79:1534-1538, 1997
PubMed
15) Ishihara M, et al:Fifteen-year trend in the treatment and outcome of acute myocardial infarction in Japan. Cir J 66:178-181, 2002
 
16) Ishikawa K et al:Modification of treatment strategies over a period of 14 years has markedly reduced cardiac events among post-myocardial infarction patients. Cir J 66:881-885, 2002
 
17) Ki njo K, et al:Impact of high-sensity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 91:931-939, 2003
 
18) Ueshima K, et al:Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective study. Am Heart J 148:1-8, 2004
 
19) Kinoshita N, et al:Longitudinal study of acute myocardial infarction in the southeast Osaka district from 1988-2002. Circ J 69:117-175, 2005
 
20) Kinjo K, et al:Impact of smoldng status on long-term mortality in patients with acute myocardial infarction. Circ J 69:7-12, 2005
PubMed
21) Nicod P, et al:Short-and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patients population. Circulation 79:528-536, 1989
 
22) Berger CJ, et al:Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q wave myocardial infarction in the Framingham heart study. JAMA 268:1545-1551, 1992
PubMed
23) Tcheng JE, et al:Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intem Med 117:18-24, 1992
 
24) Launbjerg J, et al:Ten year mortality in patients with suspected acute myocardial infarction. BMJ 308:11961199, 1994
 
25) Mark DB, et al:Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circuladon 89:2015-2025, 1994
PubMed
26) Herzog CA, et al:Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339:799-805, 1998
PubMed
27) Abrahamsson P, et al:Improved long term prognosis after myocardial infarction 1984-1991. Eur Heart J 19:1512-1517, 1998
 
28) Goldberg RJ, et al:Age-related trends in short-and long-term survival after acute myocardial infarction:a 20-year population-based perspective (1975-1995). Am Heart J 82:1311-1317, 1998
 
29) Feinberg MS, et al:Prognositic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol 86:903-907, 2000
 
30) Stewart AW, et al:Trends in three-year survival following acute myocardial infarction. Eur Heart J 20:803-807, 1999
PubMed
31) Chertow GM, et al:Survival after acute myocardial infarction in patients with end-stage renal disease:results from the cooperative cardiovascular project. Am J Kidney Dis 35:1044-1051, 2000
PubMed
32) Capewell S, et al:Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 21:1833-1840, 2000
 
33) Furman MI, et al:Twenty-two year (1975-1997) trends in the incidence, inhospital and long-term case fatality rates from initial Q-wave and non-Q wave myocardial infarction:a multi-hospital, community-wide perspective. J Am Coll Cardiol 37:1571-1580, 2001
PubMed
34) Roger VL, et al:Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted coutry, Minnesota, 1979 to 1994. Ann Intem Med 136:341-348, 2002
 
35) Wright RS, et al:Acute myocardial infarction and renal dysfunction:ahigh-risk combination. Ann Intern Med 137:563-570, 2002
 
36) Danchin N, et al:Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome:results from the French nationwide USCI 2000 registry. Circulation 110:1909-1915, 2004
 
37) Bursi F, et al:Heart failure and death after myocardial infarction in the community. The emerging role of mitral regurgitation. Circulation 111:295-301, 2005
PubMed
38) Terkeisen CJ, et al:Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction:observations from an unselected cohort. Eur Heart J 26:1 & 26, 2005
 
39) Terrin ML, et al:Two-and three-year results of thrombolysis in myocardial infarction (TIMI) phase II clinical trial. J Am Coll Cardiol 22:1763-1772, 1993
PubMed
40) Madsen JK, et al:Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation 96:748-755, 1997
PubMed
41) Baigent C, et al:ISIS-2:10-year survival among patients with suspected acute myocardial infarction in randomized comparison of intravenous streptokinase, oral aspirin, both or neither. Brit Med J 316:1337-1343, 1998
PubMed
42) Franzosi MG, et al:Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Results of the Gruppo Italiano per lo Studio della Soprawivenza nell Infarcto-1 study. Circulation 98:2659-2665, 1988
 
43) French JK, et al:Survival 12 year after randomization to streptokinase:the influence of thrombolysis in myocardial infarction flow at three to four weeks. J Am Coll Cardiol 34:62-69, 1999
 
44) Nunn CM, et al:Long-term outcome after primary angioplasty:report from the Primary Angioplasty in Myocardial Infarction (PAMI-1) trial. J Am Coll Cardiol 33:640-646, 1999
 
45) Zijlstra F, et al:Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341:1413-1419, 1999
PubMed
46) Pfeffer MA, et al:Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893-1906, 2003
 
47) van Domburg RT, et al:Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol 46:15, 2005
PubMed
48) Edmond M, et al:Long-term survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 90:2647-2657, 1994
 
49) Morrow DA, et al:TIMI risk score for ST-elevation myocardial infarction:a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031-2037, 2000
PubMed
P.85 掲載の参考文献
1) ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 33:2092, 1999
PubMed
2) AHA/ILCOR guidelines. Part 7:The era of repurfusion. Section 1:acute coronary syndromes (acute myocardial infarction). Circulation 102 (suppl I):1-172, 2000
 
3) 急性冠症候群の診療に関するガイドライン. Circ J 66 (suppl IV):1123, 2002
 
4) 急性冠症候群の診療に関するガイドライン (ダイジェスト版). Circ J 66 (suppl IV):1165, 2002
 
5) Braunwald, et al:ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction:executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on thc management of patients with unstable angina). Circulation 102:1193, 2000
 

疾患編

P.96 掲載の参考文献
1) Quiroz R, et al:Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism. JAMA 293:2012-2017,2005.
PubMed
2) Keeley EC, et al:Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:aquantitative review of 23 randomised trials. Lancet 361:13-20, 2003.
 
3) Ross AM, et al:A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction:the PACT trial J Am Coll Cardiol 34:1954-1962,1999.
 
4) Bonnefoy E, et al:Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction:arandomized study. Lancet 360:825-829, 2002.
 
P.105 掲載の参考文献
1) Rude RE, Poole WK, Muller JE, et al:Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3, 697 patients. Arn J Cardiol 52:936-942, 1983.
 
2) Marrott P, Chopra MP, Portal RW, et al:Discrepancies between electrocardiographic and enzyme evidence of myocardial infarction. Br Heart J 35:1240-1244, 1973.
PubMed
3) WEISS MM, WEISS MM Jr:The electrocardiogram in myocardial infarction. AMA Arch Intern Med 101:1126-1128, 1958.
PubMed
4) Rouan GW, Lee TH, Cook EF, et al:Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). Am J Cardiol 63:1087-1092, 1989.
PubMed
5) Lee TH, Cook EF, Weisberg MC, et al:Impact of the availability of a prior electrocardiogram on the triage of the patient with acute chest pain. J Gen Intem Med 5:381-388, 1990.
 
6) Huey BL, Beller GA, Kaiser DL, et al:Acomprehensive analysis of myocardial infarction due to left circumflex artery occlusion:comparison with infarction due to right coronary artery and left anterior descending artery occlusion. J Am Coll Cardiol 12:1156-1166, 1988.
 
7) Blanke H, Cohen M, Schlueter GU, et al:Electrocardiographic and coronary arteriographic correlations during acute myocardial infarction. Am J Cardiol 54:249-255, 1984.
PubMed
8) Perloff THE RECOGNITION OF STRICTLY POSTERIOR MYOCARDIAL INFARCTION BY CONVENTIONAL SCALAR ELECTROCARDIOGRAPHY. Circulation 30:706-718, 1964.
PubMed
9) Boden WE, Kleiger RE, Gibson RS, et al:Electrocardiographic evolution of posterior acute myocardial infarction:importance of early precordial ST-segment depression. Am J Cardiol 59:782-787, 1987.
PubMed
10) Casas RE, Marriott HJ, Glancy DL:Value of leads V7-V9 in diagnosing posterior wall acute myocardial infarction and other causes of tall R waves in V1-V2. Am J Cardiol 80:508509, 1997.
 
11) Matetzky S, Freimark D, Feinberg MS, et al. Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9:"hidden"ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol 34:748-753, 1999.
PubMed
12) Hands ME, Cook EF, Stone PH, et al:Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J 116:23-31, 1988.
PubMed
13) Sgarbossa EB, Pinski SL, Barbagelata A, et al:Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med 334:481-487, 1996.
 
14) Gussak I, Zhou SH, Rautaharju P, et al:Right bundle branch block as a cause of false-negative ECG classification of inferior myocardial infarction. J Electrocardiol 32:279-284, 1999.
PubMed
P.113 掲載の参考文献
1) 2000-2001年度合同研究班報告 (循環器病の診断と治療に関するガイドライン). 急性冠症候群の診療に関するガイドライン. Circ J 66:1123-1163, 2002.
 
2) Ryan TJ, et al:1999 Update:ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:Executive Summary and Recommendations:A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 100:10161030, 1999.
 
P.120 掲載の参考文献
1) Ryan TJ, et al:ACC/AHA Guideline for the management of patients With acute myocardial infarction. J Am Coll Cardiol, 1996.
PubMed
吉川純一:臨床心エコー図学, 文光堂.2001.
 
P.127 掲載の参考文献
1) 2000-2001年度合同研究班報告 (循環器病の診断と治療に関するガイドライン). 急性冠症候群の診療に関するガイドライン. Circ J 66:1123-1163, 2002.
 
2) ACC/AHA guideline update for the management of patients with unstable angina and non-St-segment elevation myocardial infarction-2002:Summary article. A report of the American collage of cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the management of patients with unstable angina). Circulation, 1893-1900, 2002.
 
P.138 掲載の参考文献
1) Lown B, Fakhro AM, Hood WB, et al:The coronary care unit. New prospectives and directions. JAMA 199:156, 1967.
 
2) Bigger JT Jr, Dresdale RJ, Heissenbuttel RH, et al:Ventricular arrhythmias in ischemic heart disease:mechanism, prevalence, significance, and management. Prog Cardiovasc Dis 19:255-300, 1977.
 
3) Tofier GH, Stone PH, Muller JE, et al:Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size. Am J Cardiol 60:755-761, 1987.
PubMed
4) Volpi A, Maggioni A, Franzosi MG, et al:In hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med 317:257-261, 1987.
PubMed
5) Behar S, Coldbourt U, Reicher-Reiss H, et al:Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study, Am J Cardiol 66:120811211, 1990.
 
6) Volpi A, Cavalli A, Franzosi MG, et al:One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Study della Streptochinasi nell' Infarto miocardico) investigators. Am J Cardiol 63:1174-1178, 1989.
PubMed
7) O'Doherty M, Taylar DI, Quinn E, et al:Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J 286:1405-1408, 1983.
 
8) Volpi A, Carvalli A, Santoro E, et al:Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Invetigators. Ciculation 82:1279-1288, 1990.
 
9) Behar S, Reicher-Reiss H, Sheckter M, et al:Frequency and prognostic significance of secondary ventricular fibrillation complicating acute myocardial infarction. SPRINT Study Group. Am J Cardiol 71:152-156, 1993.
 
10) Newby KH, Thompson T, Stebbins A, et al:Sustained ventricular arrhythmias in patients receiving thrombolytic therapy:incidence and outcomes. The GUSTO Invetigators. Circulation 98:2567-2573, 1998.
 
11) Mont L, Cinca J, Blanch P, et al:Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction. J Am Coll Cardiol 28:1670-1676.
PubMed
12) Goldberg RJ, Zevallos JC, Yarzebski J, et al:Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study). Am J Cardiol 69:11351141, 1992.
 
13) Behar S, Zissman E, Zion M, et al:Complete atrioventricular block complicating inferior acute wall myocardial infarction:short-and long-term prognosis. Am Heart J 125:1622-1627, 1993.
 
14) Nicod P, Gilpin E, Dittrich H, et al:Long-term outcome in patients with inferior myocardial infarction and complete alrioventricular block. J Am Coll Cardiol 12:589-594, 1988.
 
15) Clemmensen P, Bates ER, Califf RM, et al:Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group. Am J Cardiol 67:225-230, 1991.
 
16) Berger PB, Ryan TJ:Inferior myocardial infarction. High-risk subgroups. Circulation 81:401-411, 1990.
PubMed
17) Ricou F, Nicod P, Gilpin E, et al:Influence of right bundle branch block on short-and long-term survival after actlte anterior myocardial infarction. J Am Coll Cardiol 17:858-863, 1991.
 
18) Koon K, Salim Y. Curt D:Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 270:1589-1595, 1993.
 
19) Yusuf S, Peto R, Lewis J, et al:Beta blockade during and after myocardial infarction:an overview of the randomized trials. Prog Cardiovasc Dis. Mar-Apr 27 (5):335-371, 1985.
 
20) The CAPRICORN investigators:Effect of carvedilol on outcome after myocardial infarction in patients with left-ventriculardys function;the CAPRICORN randomized trial. Lancet 357:13851390, 2001.
 
21) Huikuri HV, Tapanainen, Lindgren K, et al:Prediction of sudden cardiac death after myocardial infarction in the betablocking era. J Am Coll Cardiol 42:652-658, 2003.
PubMed
22) Camm AJ, Julian D, Janse G, et al:The european myocardial infarct amiodarone trial (EMIAT). Am J Cardiol 72:95F-98F, 1993.
PubMed
23) Cairns JA, Connolly SJ, Roberts R, et al:Randomized trial of outcome after myocardial Infarction In patients with frequent or repetitive ventricular premature depolarization:CAMIAT. Lancet 349:675, 1997.
PubMed
24) Elzari MV, Martinez JM, Belziti C, et al:Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. GEMICA study investigators, GEMA group, Buenos Aires, Argentina. Grupo de Estudios Multicentricosen Argentina. Eur Heart J 21 (3):198-205, 2000.
 
P.144 掲載の参考文献
1) Fuster V, Badimon L, Badimon JJ, et al:The pathogenesis of coronary artery disease and the acute coronary syndromcs (First of two parts). N Eng J Med 326:242-250, 1992.
 
2) Killip T, et al:Treatment of myocardial infarction in a coronary care unit. Am J Cardiol 20:457-464, 1967.
 
3) Fibrinolytic Therapy Trialists' (FTT) Collaborate Group:Indications for fibrinolytic therapy in suspected acute myocardial infarction:collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 343:311-322, 1994.
PubMed
4) Weaver WD, Cerqueria M, Hallstrom AP, et al:Prehospital-initiated vs hospital-initiated thrombolytic therapy:the Myocardial Infarction Triage and Intervention Trial JAMA 270:1211-1216, 1993,
 
5) Antman EM, Anbe DT, Armstrong PW, et al:ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction-Excutive Summary:areport of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the management og Patients With Acute Myocardial Infarction). Circulation 110:588-636, 2004.
 
6) Hochman JS, Sleeper LA, Webb JG, et al:for the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341:625-634. 1999.
PubMed
7) Forrester JS, Diamond GA, Swan HJ, et al:Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 39 (2):137-145, 1977.
PubMed
P.153 掲載の参考文献
1) Moreno R, et al:Frequency of left ventricular free-wall rupture in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 85:757-760, 2000.
PubMed
2) Ryan TJ, et al:1999 update:ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:Executive Summary and Recommendations:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 100:10161030, 1999.
 
3) Aiba T, et al:Appropriate indications for the use of a percutaneous cardiopulmonary support system in cases with cardiogenic shock complicating acute myocardial infarction. Jpn Circ J 65:145-149. 2001.
PubMed
P.159 掲載の参考文献
1) Antman EM, Anbe DT, Armstrong PW, et al:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction:executive summary:areport of ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). Circulation 110:588-636, 2004.
 
2) 上松瀬勝男, 石川欽司, 児玉和久, ほか:急性心筋梗塞の診療エビデンス集. EBMより作成したガイドライン. J Jpn Coron Assoc 7:Sl-S-55, 2001.
 
3) Birnbaum Y, Fishbein MC, Blanche C, et al:Ventricular septal rupture after acute myocardial infarction. N Engl J Med 347:1426-1432, 2002.
PubMed
P.164 掲載の参考文献
1) Antman EM, et al:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction:executive summary:a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on Management of Patients With Acute Myocardial Infarction). Circulation 110:588-636, 2004.
PubMed
2) BARI investigators:Seven-year cutcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetes status. J Am Coll Cardiol 35:1122-1129, 2000.
 
3) Abizaid A, et al:Clinical and economic impat of diabetes mellitus on percutaneous and surgical treatment of multivessel disease patients:insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104:533-538, 2001.
 
P.170 掲載の参考文献
1) Konstam MA, Kronenberg MW, Rousseau MF, et al:Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation 88:2277-2283, 1993.
 
2) Mukoyama M, Nakao K, Saito Y, et al:Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323:757-758, 1990.
PubMed
3) Kameda K, Matsunaga T, Abe N, et al:Correlation of oxidative stress with the activity of matrix metalloproteinase in patients with coronary artery disease:possible role for left ventricular remodeling. Eur Heart J 24:2180-2185, 2003.
PubMed
4) Sutton MSJ, Lee D, Rouleau JL, et al:Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction. Circulation 107:2577-2582, 2003.
 
5) Morita E, Yasue H, Yoshimura M, et al:Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1):82-91, 1993.
PubMed
P.179 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (1998～1999年度合同研究班報告). 冠動脈疾患におけるインターベンション治療のガイドライン (冠動脈バイパス術を含む) -待機的インターベンション. Jpn Circ J 64:Suppl IV, 1009-1022, 2000.
 
2) Eagle KA, et al:ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:1168-1176, 2004.
 
3) Smith SC Jr, et al:ACC/AHA guidelines for percutaneous coronary intervention:Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 37:22152239, 2001.
 
4) Edmond M, et al:Long term survival of medically treated patients in the coronary artery surgery study (CASS). Circulation 90:2645-2657, 1994.
 
5) RITA-2 trial participants:Coronary angioplasty versus medical therapy for angina:the second Randomised Intervention Treatment of Angina (RITA-2). Lancet 350:461-468, 1997.
PubMed
6) Patrick W Serruys, et al:Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease. N Engl J Med 344:1117-1124, 2001.
 
P.186 掲載の参考文献
1) Lown B, Graboys TB:Management of patients with malignant ventricular arrythmi as, Am J Cardiol 39:91(>914, 1977.
 
2) 杉薫:Lown分類の意義. 臨床医 17:54-57, 1991.
 
3) Echt DS, Liebson PR, Mitchell LB, et al:Mortality and morbidity in patients receiving encainide, flecainide, or placedo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781-788, 1991.
 
4) Cairns JA, Connolly SJ, Pobert R, et al:Ramdomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarization:CAM IAT. The Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investgators. Lancet 349:675-682, 1997.
 
5) Julian DG, Camm AJ, Frajgim G, et al:Randomised tial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction. Lancet 349:667-674, 1997.
 
6) Vorperin VR, Havighurst TC, Miller S, et al:Adverse effect of low-dose amiodarone:ameta analysis. J Am coll Crdidiol 30:791-798, 1997.
 
7) The ESVEM investigators:The ESVEM trial:Electrophisiologic study versus elevtrocardiographic monitoring for antiarrhythmic thrapy of ventricular tachyarrhythmias. Circulation 79:1354-1360, 1989.
 
P.193 掲載の参考文献
1) The antiarrhythmics versus implantable defibrllators (AVID) investigators:A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:15761583, 1997.
 
2) Connolly SJ, Michael G, Roberts RF, et al:Canadian implantable defibrillator study (CIDS). A randomized trial of implantable cardioverter defibrillator against amiodarone. Circulation 101:1297-1302, 2000.
 
3) Moss AJ, Hall WJ, Cannon DS, et al:Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation trial (MADIT) Investigators. N Engl J Med 335:1933-1940, 1996.
 
4) Moss AJ, Zareba W, Hall WJ, et al:Multicenter Automatic Defibrillator Implantation trial II (MADIT II) Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-833, 2002.
 
5) Bardy GH, Lee KL, Mark DB, et al:SCD-HeFT Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med Jan 20;352 (3):225-237, 2005. Erratum in:N Engl J Med May 19;352 (20):2146, 2005.
 
6) Hansson L, et. al:Effect of intensive blood-pressure lowering and low-dose aspirin on patients with hypertentions:principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 351:1755-1762, 1998.
 
7) The CARICORN investigators:Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction. The CPRICORN randomized trial. Lancet 357:1385-1390. 2001.
PubMed
8) SOLVD Investigators:Effect of enarapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325:239-302, 1991.
 
P.199 掲載の参考文献
1) 日本透析医学会統計調査委員会:わが国の慢性透析療法の現況 (2003年12月31日現在).
 
2) Feuvre CL, Dambrin G, Helft G, et al:Clinical Outcome Following Coronary Angioplasty in Dialysis Patients:A Case-Control Study in The Era of Coronary Stenting. Heart 85:556-560, 2001.
 
3) ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction ミ Executive Summary. Vol. 110 No. 5:586-636, 2004.
 
4) 平澤博之:CHDFの理論と実際-原理・施行法編-.総合医学社, 1998.
 
5) NKF-DOQI Clinical Practice Guidelines For the Treatment of Anemia of Chronic Renal Failure. Am J Kidney Dis Vol 30 No 4 Supple 3, 1997.
 
P.205 掲載の参考文献
1) Okumura K, et al:Multivessel coronary spasm in patients with variant angina:a study with intracoronary injection of acetylcholine. Circulation 77:535-542, 1988.
PubMed
2) Kugiyama K, et al:Simultaneous multivessel coronary artery spasm demonstrated by quantitative analysis of thallium-201 single-photon emission computed tomography. Am J Cardiol 60:1009-1014, 1987.
PubMed
3) Miller DD, et al:Clinical characteristics associated With sudden death in patients with variant angina. Circulation 66:588-592, 1982.
PubMed
4) Nakao K, et al:Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol 80:545-549, 1997.
PubMed
5) Yasue H, et al:Long-term prognosis for patients with variant angina and influential factors. Circulation 78:1-9, 1988.
PubMed
6) Antman EM, et al:ACC/AHA guidelines for the management of patients with acute myocardial infarction-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 110:586-636, 2004.
 
7) Okumura K, et al:Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 12:883-888, 1988.
PubMed
8) Pristipino C, et al:Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101:1102-1108, 2000.
PubMed
9) Nakayama M:T-786→Cmutation in the 5:-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-2870, 1999.
 
P.211 掲載の参考文献
1) Canpeau L, et al:Grading of angina pectoris. Circulation 544:522, 1976.
 
2) Austen WG, et al:A reporting system on patients evaluated for coronary artery disease. Circulation 51:5, 1975.
PubMed
3) Barunwald E, Unstable angina:Classification. Circulation 80:410, 1989.
 
P.216 掲載の参考文献
1) 鈴木知己, 平盛勝彦:狭心症の病歴からの臨床診断. medicina 35:598-601, 1998.
 
2) Braunwald E, et al:Diagnosing and managing unstable angina. Circulation 90:613-622, 1994.
PubMed
3) Braunwald E, et al:ACC/AHA guideline update for the management of patients with unstable angina and non-ST elevation myocardial infarction. Circulation 106:1893-1900, 2002.
PubMed
P.224 掲載の参考文献
1) 2000-2001年度合同研究班報告 (循環器病の診断と治療に関するガイドライン) 急性冠症候群の診断に関するガイドライン. Circ J 66:1123-1163, 2002.
 
2) Gluckman TJ, Sachdev M, Schulman SP, et al:A simple approach to the management of Non-ST-segment elevation acute coronary syndromes. JAMA 293:349-357, 2005.
 
3) Cannon CP, Braunwald E, McCabe CH, et al:Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495-1504, 2004.
PubMed
P.230 掲載の参考文献
1) ACC/AHA Guidelines for Exercise Testing, A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 106:1883-1892, 2002.
 
2) 慢性虚血性心疾患の診断と病体把握のための検査法の選択基準に関するガイドライン. 循環器病の診断と治療に関するガイライン;日本循環器学会誌56:913920, 2001.
 
P.235 掲載の参考文献
1) Yasue H, et al:Coronary Spasm:Clinical features and pathogenesis. Intern Med 36:760. 1997.
PubMed
2) Yasue H, et al:Long term prognosis for patients with variant angina and influential factors. Circulation 78:1, 1988.
PubMed
3) Yamagishi M, et al:Lesion severity and hypercholesterolemia determine long term prognosis of vasospastic angina treated with calcium channel antagonists. Circ J 67:1029, 2003.
PubMed
4) Nakao K, et al:Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol 80:545,1997.
PubMed
5) Okumura K, et al:Sensitivity and specificity on intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 12:883, 1988.
PubMed
6) Mamiton JK, et al:Arenaissance of provocative testing for coronary spasm. J Am Coll Cardiol 35:1857, 2000.
 
7) 2000-2001度合同研究班報告 (循環器病の診断と治療に関するガイドライン). 急性冠症候群の診療に関するガイドライン. Circ J 66:1123, 2002.
 
P.241 掲載の参考文献
1) 奥村健, ほか:冠攣縮性狭心症. 心臓病学, 第一版. pp840-850, 医学書院, 1995.
 
2) Prinzmetal M, et al:A variant form of angina pectoris. Am J Med 27:375-388, 1959.
PubMed
3) Yasue H, et al:Prinzmetal's variant form of angina pectoris as a manifestation of alpha-adrenergic mediated coronary artery spasm:Documentation by coronary arteriography. Am Heart J 91:148-155, 1976.
PubMed
4) Furberg CD, et al:Nifedipine, dose-related increase in mortality in patients with coronary heart disease. Circulation 87:808-814, 1993.
 
5) 塚本隆裕, ほか:Denopamineが著効した冠攣縮性狭心症の2例. Jpn Circ J 62 (Suppl):II-645, 1999.
 
P.248 掲載の参考文献
1) ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 1999;33:2092-197.
PubMed
2) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina. Circulation. 2003;107:149-58.
PubMed
3) ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines). Circulation. 2001;103:3019-41.
PubMed
4) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. J Am Coll Cardiol. 2004;44:1146-54
 
5) Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries. Circulation. 2001;103:192-195
 
6) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346:1773-80.
PubMed
7) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.
 
8) Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the メ real world モ The RESEARCH registry. Circulation. 2004;109:190-195.
 
P.253 掲載の参考文献
1) 動脈硬化性疾患診療ガイドライン2002年版. 日本動脈硬化学会.
 
2) 高脂血症治療ガイドライン2004年版. 日本動脈硬化学会.
 
3) 高血圧治療ガイドライン2004. 日本高血圧学会.
 

書評

最近チェックした商品履歴

Loading...